First clinical multicenter experience with the new Pipeline Vantage flow diverter.
Dominik F VollherbstH Saruhan CekirgeIşıl SaatciFeyyaz BaltaciogluBaran OnalOsman KocRiitta RautioMatias SinisaloAlejandro TomaselloPedro VegaMario Martínez-GaldámezJeremy LynchVitor Mendes PereiraMartin BendszusMarkus A MöhlenbruchPublished in: Journal of neurointerventional surgery (2022)
The new PV FD is safe and feasible for the treatment of intracranial aneurysms. The short-term occlusion rates are promising but need further assessment in prospective long-term follow-up studies.